Effectiveness of auriculotherapy for uncontrolled mild hypertensio

Completed

• Conditions: ncontrolled mild hypertension; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN26037089
• Lead Sponsor: Food and Health Bureau (Hong Kong)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-08-03
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1. Borderline-controlled hypertension was defined in the present study as blood pressure (BP) remaining above 140/90 mmHg even when the patient was on anti-hypertensive therapy in accordance with the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) guideline.
2. Chinese patients with uncontrolled mild hypertension

Exclusion Criteria

1. Secondary hypertension
2. Upper limit of BP more than 160/99 mmHg (as a precaution to exclude high-risk cases and to ensure only cases with mild hypertension were recruited)
3. Pacemakers/implanted electrical devices
4. Pregnancy
5. A history of coronary artery disease or stroke, or comorbid illnesses such as diabetes or chronic kidney disease
6. Regular maintenance medications (apart from anti-hypertensives) which may affect BP
7. Aural injuries or infections

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean Arterial Pressure (MAP) was used as the main outcome measure in this study owing to its clinical and physiological significance in both the representation of perfusion pressure and the effect on the calculation of hemodynamic variables. After a 10-minute rest, the participants blood pressure readings were recorded using the Datascope Electronic Sphygmomanometer at baseline, at weekly visits to the clinic during the 4-week treatment course, and at 1 month and 2 months following the whole course. Datascope is one of the valid blood pressure measuring devices recently recommended by the European Society of Hypertension for clinical use in hospitals.

Secondary Outcome Measures

Name	Time	Method
Self reported by the participants at the end of the treatment course and included:<br>1. Frequency of nocturnal polyuria<br>2. Perceived sleep condition<br>3. Calmness of mind<br>4. Appetite